The Library
The insect pathogen Serratia marcescens Db10 uses a hybrid non-ribosomal peptide synthetase-polyketide synthase to produce the antibiotic althiomycin
Tools
Gerc, Amy J., Song, Lijiang, Challis, Gregory L., Stanley-Wall, Nicola R. and Coulthurst, Sarah J.. (2012) The insect pathogen Serratia marcescens Db10 uses a hybrid non-ribosomal peptide synthetase-polyketide synthase to produce the antibiotic althiomycin. PLoS One, Vol.7 (No.9). e44673. ISSN 1932-6203
|
Text
WRAP_Song_iournal.pone.0044673.pdf - Published Version Download (901Kb) | Preview |
Official URL: http://dx.doi.org/10.1371/journal.pone.0044673
Abstract
There is a continuing need to discover new bioactive natural products, such as antibiotics, in genetically-amenable micro-organisms. We observed that the enteric insect pathogen, Serratia marcescens Db10, produced a diffusible compound that inhibited the growth of Bacillis subtilis and Staphyloccocus aureus. Mapping the genetic locus required for this activity revealed a putative natural product biosynthetic gene cluster, further defined to a six-gene operon named alb1-alb6. Bioinformatic analysis of the proteins encoded by alb1-6 predicted a hybrid non-ribosomal peptide synthetase-polyketide synthase (NRPS-PKS) assembly line (Alb4/5/6), tailoring enzymes (Alb2/3) and an export/resistance protein (Alb1), and suggested that the machinery assembled althiomycin or a related molecule. Althiomycin is a ribosome-inhibiting antibiotic whose biosynthetic machinery had been elusive for decades. Chromatographic and spectroscopic analyses confirmed that wild type S. marcescens produced althiomycin and that production was eliminated on disruption of the alb gene cluster. Construction of mutants with in-frame deletions of specific alb genes demonstrated that Alb2-Alb5 were essential for althiomycin production, whereas Alb6 was required for maximal production of the antibiotic. A phosphopantetheinyl transferase enzyme required for althiomycin biosynthesis was also identified. Expression of Alb1, a predicted major facilitator superfamily efflux pump, conferred althiomycin resistance on another, sensitive, strain of S. marcescens. This is the first report of althiomycin production outside of the Myxobacteria or Streptomyces and paves the way for future exploitation of the biosynthetic machinery, since S. marcescens represents a convenient and tractable producing organism.
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QD Chemistry Q Science > QH Natural history > QH301 Biology R Medicine > RS Pharmacy and materia medica |
| Divisions: | Faculty of Science > Chemistry |
| Library of Congress Subject Headings (LCSH): | Serratia marcescens -- Genetics, Antibiotics -- Synthesis |
| Journal or Publication Title: | PLoS One |
| Publisher: | Public Library of Science |
| ISSN: | 1932-6203 |
| Date: | September 2012 |
| Volume: | Vol.7 |
| Number: | No.9 |
| Page Range: | e44673 |
| Identification Number: | 10.1371/journal.pone.0044673 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Open Access |
| Funder: | Royal Society of Edinburgh, Scotland, Wellcome Trust (London, England), Advantage West Midlands (AWM), European Regional Development Fund (ERDF) |
| Grant number: | 093711/B/10/Z (WT) |
| References: | 1. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE, Jr (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38: 1279–1286. 2. Gwynn MN, Portnoy A, Rittenhouse SF, Payne DJ (2010) Challenges of antibacterial discovery revisited. Ann N Y Acad Sci 1213: 5–19. 3. Challis GL (2008) Genome mining for novel natural product discovery. Journal of medicinal chemistry 51: 2618–2628. 4. Zerikly M, Challis GL (2009) Strategies for the Discovery of New Natural Products by Genome Mining. Chembiochem 10: 625–633. 5. Challis GL (2008) Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology 154: 1555–1569. 6. Kim J, Choi JN, Kim P, Sok DE, Nam SW, et al. (2009) LC-MS/MS profilingbased secondary metabolite screening of Myxococcus xanthus. Journal of microbiology and biotechnology 19: 51–54. 7. Keating TA, Walsh CT (1999) Initiation, elongation, and termination strategies in polyketide and polypeptide antibiotic biosynthesis. Curr Opin Chem Biol 3: 598–606. 8. Finking R, Marahiel MA (2004) Biosynthesis of nonribosomal peptides. Annu Rev Microbiol 58: 453–488. 9. Chan YA, Boyne MT II, Podevels AM, Klimowicz AK, Handelsman J, et al. (2006) Hydroxymalonyl-acyl carrier protein (ACP) and aminomalonyl-ACP are two additional type I polyketide synthase extender units. Proc Natl Acad SciUS A 103: 14349–14354. 10. Chan YA, Podevels AM, Kevany BM, Thomas MG (2009) Biosynthesis of polyketide synthase extender units. Natural Product Reports 26: 90–114. 11. Walsh CT, Gehring AM, Weinreb PH, Quadri LE, Flugel RS (1997) Posttranslational modification of polyketide and nonribosomal peptide synthases. Current opinion in chemical biology 1: 309–315. 12. Lambalot RH, Gehring AM, Flugel RS, Zuber P, LaCelle M, et al. (1996) A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol 3: 923– 936. 13. Fischbach MA, Walsh CT (2006) Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 106: 3468–3496. 14. Yamaguchi H, Nakayama Y, Takeda K, Tawara K, Maeda K, et al. (1957) A new antibiotic, althiomycin. The Journal of antibiotics 10: 195–200. 15. Fujimoto H, Kinoshita T, Suzuki H, Umezawa H (1970) Studies on the mode of action of althiomycin. J Antibiot (Tokyo) 23: 271–275. 16. Burns DJ, Cundliffe E (1973) Bacterial-protein synthesis. A novel system for studying antibiotic action in vivo. Eur J Biochem 37: 570–574. 17. Sakakibara H, Naganawa H, Ono M, Maeda K, Umezawa H (1974) The structure of althiomycin. The Journal of antibiotics 27: 897–899. 18. Inami K, Shiba T (1985) Total Synthesis of Antibiotic Althiomycin. Bulletin of the Chemical Society of Japan 58: 352–360. 19. Zarantonello P, Leslie CP, Ferritto R, Kazmierski WM (2002) Total synthesis and semi-synthetic approaches to analogues of antibacterial natural product althiomycin. Bioorganic & medicinal chemistry letters 12: 561–565. 20. Kunze B, Reichenbach H, Augustiniak H, Hofle G (1982) Isolation and identification of althiomycin from Cystobacter fuscus (myxobacterales). The Journal of antibiotics 35: 635–636. 21. Cortina NS, Revermann O, Krug D, Muller R (2011) Identification and characterization of the althiomycin biosynthetic gene cluster in Myxococcus xanthus DK897. Chembiochem 12: 1411–1416. 22. Harris AK, Williamson NR, Slater H, Cox A, Abbasi S, et al. (2004) The Serratia gene cluster encoding biosynthesis of the red antibiotic, prodigiosin, shows species- and strain-dependent genome context variation. Microbiology 150: 3547–3560. 23. Coulthurst SJ, Barnard AM, Salmond GP (2005) Regulation and biosynthesis of carbapenem antibiotics in bacteria. Nat Rev Microbiol 3: 295–306. 24. Williamson NR, Fineran PC, Leeper FJ, Salmond GP (2006) The biosynthesis and regulation of bacterial prodiginines. Nat Rev Microbiol 4: 887–899. 25. Flyg C, Kenne K, Boman HG (1980) Insect pathogenic properties of Serratia marcescens: phage-resistant mutants with a decreased resistance to Cecropia immunity and a decreased virulence to Drosophila. J Gen Microbiol 120: 173– 181. 26. Challis GL, Ravel J, Townsend CA (2000) Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains. Chemistry & biology 7: 211–224. 27. Stachelhaus T, Mootz HD, Marahiel MA (1999) The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. Chem Biol 6: 493– 505. 28. Haydock SF, Aparicio JF, Molnar I, Schwecke T, Khaw LE, et al. (1995) Divergent sequence motifs correlated with the substrate specificity of (methyl)malonyl-CoA:acyl carrier protein transacylase domains in modular polyketide synthases. FEBS letters 374: 246–248. 29. Krebs C, Matthews ML, Jiang W, Bollinger JM, Jr (2007) AurF from Streptomyces thioluteus and a possible new family of manganese/iron oxygenases. Biochemistry 46: 10413–10418. 30. Pavlidou M, Pross EK, Musiol EM, Kulik A, Wohlleben W, et al. (2011) The phosphopantetheinyl transferase KirP activates the ACP and PCP domains of the kirromycin NRPS/PKS of Streptomyces collinus Tu 365. FEMS microbiology letters 319: 26–33. 31. Mootz HD, Finking R, Marahiel MA (2001) 49-phosphopantetheine transfer in primary and secondary metabolism of Bacillus subtilis. The Journal of biological chemistry 276: 37289–37298. 32. Quadri LE, Weinreb PH, Lei M, Nakano MM, Zuber P, et al. (1998) Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry 37: 1585– 1595. 33. Fluman N, Bibi E (2009) Bacterial multidrug transport through the lens of the major facilitator superfamily. Biochim Biophys Acta 1794: 738–747. 34. Hopwood DA (2007) How do antibiotic-producing bacteria ensure their selfresistance before antibiotic biosynthesis incapacitates them? Mol Microbiol 63: 937–940. 35. Sadar MD, Williams DE, Mawji NR, Patrick BO, Wikanta T, et al. (2008) Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells. Organic letters 10: 4947–4950. 36. Bai R, Friedman SJ, Pettit GR, Hamel E (1992) Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules. Biochemical pharmacology 43: 2637–2645. 37. Cardellina JH, Marner FJ, Moore RE (1979) Malyngamide A, a Novel Chlorinated Metabolite of the Marine Cyanophyte Lyngbya-Majuscula. Journal of the American Chemical Society 101: 240–242. 38. Paik SG, Carmeli S, Cullingham J, Moore RE, Patterson GML, et al. (1994) Mirabimide-E, an Unusual N-Acylpyrrolinone from the Blue-Green-Alga Scytonema Mirabile - Structure Determination and Synthesis. Journal of the American Chemical Society 116: 8116–8125. 39. Coulthurst SJ, Williamson NR, Harris AK, Spring DR, Salmond GP (2006) Metabolic and regulatory engineering of Serratia marcescens: mimicking phagemediated horizontal acquisition of antibiotic biosynthesis and quorum-sensing capacities. Microbiology 152: 1899–1911. 40. Coulthurst SJ, Lilley KS, Salmond GP (2006) Genetic and proteomic analysis of the role of luxS in the enteric phytopathogen, Erwinia carotovora. Molecular Plant Pathology 7: 31–45. 41. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 25: 3389–3402. 42. Petty NK, Foulds IJ, Pradel E, Ewbank JJ, Salmond GP (2006) A generalized transducing phage (phiIF3) for the genomically sequenced Serratia marcescens strain Db11: a tool for functional genomics of an opportunistic human pathogen. Microbiology 152: 1701–1708. 43. Kiley TB, Stanley-Wall NR (2010) Post-translational control of Bacillus subtilis biofilm formation mediated by tyrosine phosphorylation. Mol Microbiol 78: 947–963. 44. Jack RL, Buchanan G, Dubini A, Hatzixanthis K, Palmer T, et al. (2004) Coordinating assembly and export of complex bacterial proteins. The EMBO journal 23: 3962–3972. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/50211 |
Actions (login required)
![]() |
View Item |
Tools
Tools

